Validation Articles

T he Blend Uniformity Analysis Working Group (BUAWG) of the Product Quality Research Institute (PQRI) held a workshop about blend uniformity o­n 7–8 September 2000.Approximately 250 representatives from the pharmaceutical industry, FDA, and academia attended the workshop. The main purpose of the meeting was to create an open forum to discuss the August 1999 FDA draft guideline for routine blend uniformity testing o­n abbreviated new drug application (ANDA) products.

Roger W. Koops, Ph.D.
Journal of Validation Technology
Volume 8 Number 2 January 2002

Scott Bozzone, Ph.D.
Quality Operations,Cork, Ireland

Harry G. Brittain
Pharmaceutical Technology JULY 2002

The FDA defined Process Validation in 1987 by the following: “Process Validation is establishing documented evidence which provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specification and quality attributes.” 1The purpose of this article is to discuss how to validate a process by introducing some basic statistical concepts to use when analyzing historical data from Batch Records and Quality Control Release documents to establish specifications and quality attributes for an existing process. In an ideal world, the qualification of processing equipment, utilities, facilities, and controls would commence at the start up of a new plant or the implementation of a new system.


For full article Click Here

This article illustrates a qualification– validation strategy for moist heat sterilization and briefly discusses the sterility concept and common sterilization principles. In Part I, the authors present examples for cycle types, parameter requirements for a standard cycle as defined by pharmacopeias, methods used to design sterilization cycles, and various approaches used to measure the efficiency of the sterilization process.

For full article Click Here

WHO-EDM Dec 2001

An all-electronic validation can provide storage costs savings and ensured document legibility.

For free full article click here 

A Statistically Valid Time Frame or Number of BatchesHow large of a sample set is needed of previously recorded data to determine ranges that are truly representative of the process, and will the ranges be useful in the Validation effort and not set o­ne up for failure? This is a difficult question to answer, and it is important to note that the batches selected should have no changes between them, thus be produced with the same processing conditions. The draft FDA Guidance for Industry, Manufacturing, Processing, or Holding Active Pharmaceutical Ingredients from March of 1998 suggests that 10-30 consecutive batches be examined to assess process consistency.


For full article Click Here

Validation was hinted in the 1960s, almost four decades ago. What has changed over the last 30 o 40 years? Has the overall understanding of the term improved? Have all responsible firms truly embraced validation? Are they doing everything within their power to make validations a success? Unfortunately not. While validation is a very necessary element of any firm that falls under the scrutiny of the governing regulatory agencies – both United States and foreign – it has not received the recognition it deserves.

For full text article Click Here